HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Aesthetic Medicine

954.943

+3.1000.33%

Number of Gainers:6

Number of Losers:1

Number of Flat:6

PE:- -

High:961.507

Open:951.300

Low:949.000

Close:951.843

Volume:7.70M

Turnover:90.40M

Market Cap:156.87B

Float Cap:118.12B

Loading ...

China National Medical Products Administration: Approves 3S Guojian's Nonsteroidal Anti-Inflammatory Drug

THOMSON REUTERS

Earnings Report: China Medical System Holdings Limited Missed Revenue Estimates By 5.0%

Simply Wall St.

Hong Kong's Sisram Medical H1 Profit Falls on China Injectables Investments

Sisram Medical H1 Revenue USD 171.4 Million

THOMSON REUTERS

Press Release: Sisram Medical Delivers Solid 2026 Interim Results

SISRAM MED Posts Interim Loss as Revenue Edges Higher

Sisram Medical 1H FY26 Swings to IFRS Net Loss of Us$1.16 Million; Revenue Rises 3.6% to Us$171.4 Million

Iridex Q2 Revenue Falls as Retina Sales Decline

China Medical System (SEHK:867) Stock Revenue Push Meets Persistent Earnings Strain

Simply Wall St.

Giant Biogene's Profit Drops on Higher Distribution Expenses

Denmark's Coloplast Q3 Revenue up on Chronic Care, Urology Growth

Sweden's OssDsign Q2 Sales Rise 2.4% Gross Margin Falls

CMS Announces Interim Results: Net Profit Attributable to Shareholders Up 4.77% to RMB 986 Million

China Medical System Holdings H1 Net Income Attributable RMB 986.1 Million

THOMSON REUTERS

China Medical System H1 FY26 Profit Rises 4.3% to RMB 971.5 Million; Revenue Climbs 12.5% to RMB 4.5 Billion

Top Global Dividend Stocks To Consider In August 2026

Simply Wall St.

Modern Dental Group Sets Board Meeting to Review Interim Results, Consider Dividend

Raily Aesthetic Medicine Sets Board Meeting to Review Interim Results

Fosun Pharma Subsidiary Enters Collaboration Framework and License Agreement

Shanghai Fosun's Unit in Collaboration with Sandoz AG on 10 Biologic Products

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/stock/BK1593/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"Aesthetic Medicine","latestPrice":954.9428,"timestamp":1787708653992,"preClose":951.843,"halted":0,"volume":7696600,"delay":0,"changeRate":0.003257,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":3.099792,"latestTime":"08-26 09:44:15","open":951.2996,"high":961.5065,"low":948.9996,"amount":90403339,"amplitude":0.01314,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1787716800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787707800000,1787716800000],[1787720400000,1787731200000]],"pbRate":1.210361,"peRate":11.275622,"turnoverRate":0.000384,"increases":6,"decrements":1,"flats":6,"marketCap":156872480728,"floatMarketCap":118122902040},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":961.5065,"amplitude":0.01314,"preClose":951.843,"low":948.9996,"pbRate":"1.210361","latestPrice":954.9428,"volume":7696600,"delay":0,"open":951.2996,"prevYearClose":1094.978,"prevWeekClose":957.756,"prevMonthClose":920.614,"prevQuarterClose":846.145,"fiveDayClose":932.26,"twentyDayClose":940.305,"sixtyDayClose":925.34,"secType":"PLATE","market":"HK","turnoverRate":0.000384,"peRate":11.275622,"marketCap":156872480728,"floatMarketCap":118122902040,"timestamp":1787708653992,"nameCN":"Aesthetic Medicine"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":6,"down":1,"flat":6},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660047222","title":"China National Medical Products Administration: Approves 3S Guojian's Nonsteroidal Anti-Inflammatory Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2660047222","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660047222?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:58","pubTimestamp":1787191101,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nP8N43G01E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","01530","BK1593","HK0000165453.HKD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660792204","title":"Earnings Report: China Medical System Holdings Limited Missed Revenue Estimates By 5.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660792204","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660792204?lang=en_us&edition=fundamental","pubTime":"2026-08-20 06:48","pubTimestamp":1787179693,"startTime":"0","endTime":"0","summary":"The half-year results for China Medical System Holdings Limited ( HKG:867 ) were released last week, making it a good...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/earnings-report-china-medical-system-holdings-limited-missed","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/earnings-report-china-medical-system-holdings-limited-missed","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BYV24P56.USD","FEBU","JOYT","SG9999015945.SGD","LU2488822045.USD","GXDW","VGFPF","BK1593","00867","IE00BMCWC346.EUR","SG9999004220.SGD","IE00BGHQDM52.EUR","PMDE","IE00BVYPNQ40.USD","SG9999015986.USD","SG9999015952.SGD","RGLO","BK1191","IE00BVYPNP33.GBP","VOTE","SG9999015978.USD","DECU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660400428","title":"Hong Kong's Sisram Medical H1 Profit Falls on China Injectables Investments","url":"https://stock-news.laohu8.com/highlight/detail?id=2660400428","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660400428?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:19","pubTimestamp":1787141959,"startTime":"0","endTime":"0","summary":"Hong Kong's Sisram Medical H1 profit falls on China injectables investmentsOverviewHong Kong medical aesthetics firm's H1 revenue rose 3.6% yr/yr to $171.4 mlnNet profit and adjusted net profit declin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nL1N44G0FR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0472753341.HKD","LU2463526074.USD","IE00BMCWC346.EUR","IE00BYV24P56.USD","IE00BGHQDM52.EUR","IE000M9KFDE8.USD","LU0057025933.USD","LU0154245756.USD","LU0069063385.USD","SG9999015952.SGD","IE00BVYPNQ40.USD","LU0154245673.USD","SG9999015986.USD","IE00BVYPNP33.GBP","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","LU0203345920.USD","BK1230","BK1515","BK1589","BK4149","MADE","BK1100","00867","LU0511384066.AUD","BK1191","BK4585","CMI","IE00BZ08YR35.GBP","LU0289739343.SGD","LU0124676726.USD","LU0203347892.USD","BK1593","LU0289961442.SGD","01696","SG9999004220.SGD","01177","LU0689626769.HKD","SG9999015978.USD","00656","HK0000165453.HKD","BK4533","BK4567","BK1521","LU2488822045.USD","BK1585","SG9999015945.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660428666","title":"Sisram Medical H1 Revenue USD 171.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660428666","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660428666?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:06","pubTimestamp":1787141189,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nPLX7485R1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01696","BK1585","BK1593","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660428322","title":"Press Release: Sisram Medical Delivers Solid 2026 Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660428322","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660428322?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:00","pubTimestamp":1787140800,"startTime":"0","endTime":"0","summary":"Injectables Business Fuels Rapid Growth as APAC Drives International Revenue ExpansionHONG KONG, Aug. 19, 2026 /PRNewswire/ -- Sisram Medical Ltd , a global wellness group offering Energy-Based Devices , injectables, and other complementary solutions, today announced its unaudited consolidated interim results for the six months ended June 30, 2026 . During the Reporting Period, the Company achieved steady overall growth, propelled by accelerating momentum in its Injectables business and robust performance across the APAC region. These two growth drivers effectively mitigated headwinds in North America and broader macro uncertainties, underscoring the Company's operational stamina and strategic prudence.FINANCIAL HIGHLIGHTS-- Revenue was US$171.4 million, representing an increase of 3.6% year on. US$127.0 million, representing an increase of 16.7% YoY. Across the. region, revenues in APAC, Europe, and Middle East and Africa were US$78.4. million, representing a decrease of 21.6% YoY, wh","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Press Release: Sisram Medical Delivers Solid 2026 Interim Results","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01696","BK1585","AIPO","ARTY","QTOC","BK1593","VTHR","BK1100","AGIX","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185159084","title":"SISRAM MED Posts Interim Loss as Revenue Edges Higher","url":"https://stock-news.laohu8.com/highlight/detail?id=1185159084","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185159084?lang=en_us&edition=fundamental","pubTime":"2026-08-19 19:16","pubTimestamp":1787138207,"startTime":"0","endTime":"0","summary":"SISRAM MED (01696) has released its interim results for the 2026 fiscal period, revealing a shift into the red on the bottom line. The company generated revenue of approximately $171.4 million,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1585","01696","BK1100","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660244718","title":"Sisram Medical 1H FY26 Swings to IFRS Net Loss of Us$1.16 Million; Revenue Rises 3.6% to Us$171.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660244718","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660244718?lang=en_us&edition=fundamental","pubTime":"2026-08-19 19:11","pubTimestamp":1787137915,"startTime":"0","endTime":"0","summary":"Sisram Medical 1H FY26 swings to IFRS net loss of US$1.16 million; revenue rises 3.6% to US$171.4 millionSisram Medical Ltd. posted revenue of US$171.4 million, up 3.6% year on year.Profit attributabl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL1LWf4C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","01696","00656","BK1100","BK1230","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660947654","title":"Iridex Q2 Revenue Falls as Retina Sales Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2660947654","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660947654?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:13","pubTimestamp":1787083980,"startTime":"0","endTime":"0","summary":"Iridex Q2 revenue falls as retina sales declineOverviewLaser medical systems maker's Q2 revenue fell 7% yr/yr on weaker retina product salesGlaucoma product revenue rose 19% yr/yr, offsetting some ret","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nL1N44F0RS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","BK1593","IRIX","BK4585","BK4082","LU0889565916.HKD","SG9999015952.SGD","BK1191","SG9999015986.USD","BK4007","IE00BVYPNP33.GBP","IE00BVYPNQ40.USD","LU2488822045.USD","BK4198","IE00BGHQDM52.EUR","IE00BYV24P56.USD","NSPR","SG9999015978.USD","EYPT","00867","BK4588","SG9999004220.SGD","IE00BMCWC346.EUR","LU0109394709.USD","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660231495","title":"China Medical System (SEHK:867) Stock Revenue Push Meets Persistent Earnings Strain","url":"https://stock-news.laohu8.com/highlight/detail?id=2660231495","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660231495?lang=en_us&edition=fundamental","pubTime":"2026-08-18 19:27","pubTimestamp":1787052452,"startTime":"0","endTime":"0","summary":"China Medical System Holdings went into these half year numbers with a stock that has cooled in the short term, down around 2.6% over the past week and 3.5% over the month, despite a positive 3 month run. The market reaction into the release hinted at caution, yet the headline result is firm. First half 2026 revenue came in at ¥4,500.7m and net income excluding extra items was ¥986.1m. Basic earnings per share of ¥0.4075 in this specialty pharma group now sits against a trailing P/E of 15.9x,...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/china-medical-system-sehk867-stock-revenue-push-meets-persis","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/china-medical-system-sehk867-stock-revenue-push-meets-persis","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SG9999015986.USD","BK1593","SG9999015945.SGD","IE00BMCWC346.EUR","00867","IE00BVYPNP33.GBP","IE00BYV24P56.USD","SG9999004220.SGD","IE00BGHQDM52.EUR","SG9999015952.SGD","SG9999015978.USD","LU2488822045.USD","IE00BVYPNQ40.USD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660698034","title":"Giant Biogene's Profit Drops on Higher Distribution Expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2660698034","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660698034?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:15","pubTimestamp":1787048144,"startTime":"0","endTime":"0","summary":"Giant Biogene's profit drops on higher distribution expensesOverviewChina skincare maker's half-year revenue fell 6.3% yr/yr to RMB 2.92 blnNet profit attributable to shareholders dropped 20.5% to RMB","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nL1N44F091:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BMCWC346.EUR","SG9999015945.SGD","BK1207","02367","BK1593","LU2460026573.USD","IE00BYV24P56.USD","IE00BVYPNQ40.USD","BK0175","SGXZ81163826.USD","01361","SG9999015986.USD","SG9999004311.SGD","BK0185","LU2488822045.USD","BK0188","IE00BVYPNP33.GBP","BK1227","BK0028","SGXZ49509284.SGD","00867","SG9999015978.USD","BK0224","SG9999004220.SGD","IE00BGHQDM52.EUR","BK1191","000921","SG9999015952.SGD","BK1512","BK1500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660454174","title":"Denmark's Coloplast Q3 Revenue up on Chronic Care, Urology Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2660454174","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660454174?lang=en_us&edition=fundamental","pubTime":"2026-08-18 13:46","pubTimestamp":1787032000,"startTime":"0","endTime":"0","summary":"Denmark's Coloplast Q3 revenue up on Chronic Care, Urology growthOverviewDenmark medical devices maker's Q3 organic revenue grew 6%, EBIT up 5% in constant currenciesReported EBIT margin fell to 26% f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nL1N44F046:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015952.SGD","SG9999015978.USD","BK1593","IE00BYV24P56.USD","BK1191","SG9999004220.SGD","SG9999015986.USD","LU2488822045.USD","IE00BVYPNQ40.USD","SG9999015945.SGD","IE00BMCWC346.EUR","IE00BGHQDM52.EUR","IE00BVYPNP33.GBP","00867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660545107","title":"Sweden's OssDsign Q2 Sales Rise 2.4% Gross Margin Falls","url":"https://stock-news.laohu8.com/highlight/detail?id=2660545107","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660545107?lang=en_us&edition=fundamental","pubTime":"2026-08-18 13:11","pubTimestamp":1787029874,"startTime":"0","endTime":"0","summary":"Sweden's OssDsign Q2 sales rise 2.4% gross margin fallsOverviewSweden orthobiologics products developer's Q2 net sales grew 2.4% yr/yrGross margin for Q2 was 92.1%, down from 96.8% last year due to mi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nL1N44F03P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00867","IE00BVYPNQ40.USD","SG9999015986.USD","BK1593","NSPR","LU2488822045.USD","IE00BYV24P56.USD","SG9999015952.SGD","IE00BGHQDM52.EUR","IE00BMCWC346.EUR","SG9999015978.USD","BK4198","SG9999015945.SGD","SG9999004220.SGD","BK1191","IE00BVYPNP33.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118231284","title":"CMS Announces Interim Results: Net Profit Attributable to Shareholders Up 4.77% to RMB 986 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1118231284","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118231284?lang=en_us&edition=fundamental","pubTime":"2026-08-17 21:31","pubTimestamp":1786973474,"startTime":"0","endTime":"0","summary":"CMS has released its interim results for the first half of 2026, showing steady growth across key financial metrics. Revenue climbed 12.5% year-on-year to approximately RMB 4.5 billion, while gross...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015945.SGD","IE00BVYPNQ40.USD","SG9999004220.SGD","SG9999015952.SGD","SG9999015986.USD","BK1593","IE00BGHQDM52.EUR","BK1191","00867","IE00BMCWC346.EUR","IE00BYV24P56.USD","SG9999015978.USD","LU2488822045.USD","IE00BVYPNP33.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660743892","title":"China Medical System Holdings H1 Net Income Attributable RMB 986.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660743892","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660743892?lang=en_us&edition=fundamental","pubTime":"2026-08-17 21:23","pubTimestamp":1786973022,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nPLXBR474C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999015952.SGD","SG9999015978.USD","SG9999015945.SGD","IE00BVYPNP33.GBP","IE00BGHQDM52.EUR","00867","LU2488822045.USD","IE00BMCWC346.EUR","BK1191","IE00BYV24P56.USD","IE00BVYPNQ40.USD","SG9999015986.USD","BK1593","SG9999004220.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660543818","title":"China Medical System H1 FY26 Profit Rises 4.3% to RMB 971.5 Million; Revenue Climbs 12.5% to RMB 4.5 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2660543818","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660543818?lang=en_us&edition=fundamental","pubTime":"2026-08-17 21:23","pubTimestamp":1786972995,"startTime":"0","endTime":"0","summary":"China Medical System H1 FY26 profit rises 4.3% to RMB 971.5 million; revenue climbs 12.5% to RMB 4.5 billionChina Medical System posted turnover up 12.5% to RMB 4.5 billion for the six months ended Ju","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL7dV4j2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015952.SGD","SG9999015978.USD","SG9999015945.SGD","IE00BVYPNP33.GBP","IE00BGHQDM52.EUR","00867","LU2488822045.USD","IE00BMCWC346.EUR","BK1191","IE00BYV24P56.USD","IE00BVYPNQ40.USD","SG9999015986.USD","BK1593","SG9999004220.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660486819","title":"Top Global Dividend Stocks To Consider In August 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2660486819","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660486819?lang=en_us&edition=fundamental","pubTime":"2026-08-17 17:01","pubTimestamp":1786957314,"startTime":"0","endTime":"0","summary":"As global markets navigate mixed signals from easing inflation concerns and ongoing geopolitical tensions, investors are increasingly turning their attention to dividend stocks as a potential source of steady income amid uncertainty. With major indices like the S&P 500 showing modest gains and others such as the Dow Jones Industrial Average finishing lower, selecting dividend stocks that demonstrate resilience and consistent payouts can be an appealing strategy in today's fluctuating economic...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/3041000-choice2-main-header/1585186777117","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3041000-choice2-main-header/1585186777117"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/cn/capital-goods/szse-002811/shenzhen-cheng-chung-design-shares/news/top-global-dividend-stocks-to-consider-in-august-2026-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/cn/capital-goods/szse-002811/shenzhen-cheng-chung-design-shares/news/top-global-dividend-stocks-to-consider-in-august-2026-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["03600","BK6520","BK4588","BK1100","BK6045","L19.SI","HDV","BK1593","BK1583","BK4585","VIG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660276483","title":"Modern Dental Group Sets Board Meeting to Review Interim Results, Consider Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2660276483","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660276483?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:39","pubTimestamp":1786955988,"startTime":"0","endTime":"0","summary":"Modern Dental Group sets board meeting to review interim results, consider dividendModern Dental Group scheduled a board meeting for Aug. 27, 2026.Directors will review unaudited interim results for t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDLjJny1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1583","BK1593","03600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660483245","title":"Raily Aesthetic Medicine Sets Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660483245","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660483245?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:37","pubTimestamp":1786955825,"startTime":"0","endTime":"0","summary":"Raily Aesthetic Medicine sets board meeting to review interim resultsRaily Aesthetic Medicine will hold a board meeting on Aug. 28, 2026 to review unaudited interim results for the six months ended Ju","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL78n6vH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1209","BK1593","02135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128694046","title":"Fosun Pharma Subsidiary Enters Collaboration Framework and License Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=1128694046","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128694046?lang=en_us&edition=fundamental","pubTime":"2026-08-17 08:04","pubTimestamp":1786925065,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SH) announced that on August 16, 2026, its controlling subsidiary, Henlius, entered into a Collaboration Framework Agreement with Sandoz...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","BK1515","BK1191","02196","BK0183","BK0175","BK0096","BK0196","BK0239","BK1593","BK0187","BK0012","600196","BK0060","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660105879","title":"Shanghai Fosun's Unit in Collaboration with Sandoz AG on 10 Biologic Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2660105879","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660105879?lang=en_us&edition=fundamental","pubTime":"2026-08-17 08:02","pubTimestamp":1786924927,"startTime":"0","endTime":"0","summary":"BRIEF-Shanghai Fosun's Unit in Collaboration With Sandoz AG on 10 Biologic ProductsAug 17 -Shanghai Fosun Pharmaceutical Group Co Ltd600196.SS:SAYS UNIT SIGNS FRAMEWORK COOPERATION AGREEMENT WITH SANDOZ AGSAYS TO TEAM UP SANDOZ ON COMMERCIALIZATION, DEVELOPMENT, MANUFACTURING OF UP TO 10 BIOLOGIC PRODUCTSSource textFurther company coverage:600196.SS","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nL4N44D04R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","BK0175","BK0012","BK0028","BK0239","BK0196","BK1593","BK1191","BK1515","BK0183","600196","02196","BK0188","BK0187","BK0096"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":52,"code":"91000000","status":"200"}]}}